Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 245

Similar articles for PubMed (Select 16265127)

1.

Technology insight: calprotectin, lactoferrin and nitric oxide as novel markers of inflammatory bowel disease.

Lundberg JO, Hellström PM, Fagerhol MK, Weitzberg E, Roseth AG.

Nat Clin Pract Gastroenterol Hepatol. 2005 Feb;2(2):96-102. Review.

PMID:
16265127
2.

Rectal nitric oxide and fecal calprotectin in inflammatory bowel disease.

Reinders CA, Jonkers D, Janson EA, Stockbrügger RW, Stobberingh EE, Hellström PM, Lundberg JO.

Scand J Gastroenterol. 2007 Oct;42(10):1151-7.

PMID:
17852876
3.

Review of fecal biomarkers in inflammatory bowel disease.

Sutherland AD, Gearry RB, Frizelle FA.

Dis Colon Rectum. 2008 Aug;51(8):1283-91. doi: 10.1007/s10350-008-9310-8. Epub 2008 Jun 10. Review.

PMID:
18543035
4.

[Measurement of calprotectin in faeces].

Jahnsen J, Røseth AG, Aadland E.

Tidsskr Nor Laegeforen. 2009 Apr 16;129(8):743-5. doi: 10.4045/tidsskr.08.0010. Review. Norwegian.

5.

Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease.

D'Incà R, Dal Pont E, Di Leo V, Ferronato A, Fries W, Vettorato MG, Martines D, Sturniolo GC.

Int J Colorectal Dis. 2007 Apr;22(4):429-37. Epub 2006 Jul 13.

PMID:
16838143
6.
7.

Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome.

Silberer H, Küppers B, Mickisch O, Baniewicz W, Drescher M, Traber L, Kempf A, Schmidt-Gayk H.

Clin Lab. 2005;51(3-4):117-26.

PMID:
15819166
8.

Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome.

Otten CM, Kok L, Witteman BJ, Baumgarten R, Kampman E, Moons KG, de Wit NJ.

Clin Chem Lab Med. 2008;46(9):1275-80. doi: 10.1515/CCLM.2008.246. Erratum in: Clin Chem Lab Med. 2008;46(12):1798.

PMID:
18597588
9.

Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.

Langhorst J, Elsenbruch S, Koelzer J, Rueffer A, Michalsen A, Dobos GJ.

Am J Gastroenterol. 2008 Jan;103(1):162-9. Epub 2007 Oct 4.

PMID:
17916108
10.

Fecal lactoferrin and calprotectin after ileocolonic resection for Crohn's disease.

Scarpa M, D'Incà R, Basso D, Ruffolo C, Polese L, Bertin E, Luise A, Frego M, Plebani M, Sturniolo GC, D'Amico DF, Angriman I.

Dis Colon Rectum. 2007 Jun;50(6):861-9.

PMID:
17473939
11.

Clinical utility of calprotectin and lactoferrin as markers of inflammation in patients with inflammatory bowel disease.

Caccaro R, D'Incá R, Sturniolo GC.

Expert Rev Clin Immunol. 2010 Jul;6(4):551-8. doi: 10.1586/eci.10.26.

PMID:
20594128
12.

Accuracy of four fecal assays in the diagnosis of colitis.

Schoepfer AM, Trummler M, Seeholzer P, Criblez DH, Seibold F.

Dis Colon Rectum. 2007 Oct;50(10):1697-706.

PMID:
17762964
13.

Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse.

Gisbert JP, Bermejo F, Pérez-Calle JL, Taxonera C, Vera I, McNicholl AG, Algaba A, López P, López-Palacios N, Calvo M, González-Lama Y, Carneros JA, Velasco M, Maté J.

Inflamm Bowel Dis. 2009 Aug;15(8):1190-8. doi: 10.1002/ibd.20933.

PMID:
19291780
14.

Diagnostic value of calprotectin in irritable bowel syndrome and in inflammatory bowel disease.

Grad C, David L, Portincasa P, Dumitraşcu DL.

Rom J Intern Med. 2012 Jan-Mar;50(1):3-6. Review.

PMID:
22788087
15.

[Calprotectin: a fecal marker for diagnosis and follow-up in patients with chronic inflammatory bowel disease].

van den Bergh FA, Kolkman JJ, Russel MG, Vlaskamp RT, Vermes I.

Ned Tijdschr Geneeskd. 2003 Nov 29;147(48):2360-5. Review. Dutch.

PMID:
14677476
16.

Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease.

Konikoff MR, Denson LA.

Inflamm Bowel Dis. 2006 Jun;12(6):524-34. Review.

PMID:
16775498
17.

Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms.

Fagerberg UL, Lööf L, Myrdal U, Hansson LO, Finkel Y.

J Pediatr Gastroenterol Nutr. 2005 Apr;40(4):450-5.

PMID:
15795593
18.

The use of fecal calprotectin and lactoferrin in patients with IBD. Review.

Stragier E, Van Assche G.

Acta Gastroenterol Belg. 2013 Sep;76(3):322-8. Review.

PMID:
24261027
19.

[Fecal calprotectin in differential diagnosis of irritable bowel syndrome].

Li XG, Lu YM, Gu F, Yang XL.

Beijing Da Xue Xue Bao. 2006 Jun 18;38(3):310-3. Chinese.

20.

Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohn's disease.

Sipponen T, Savilahti E, Kärkkäinen P, Kolho KL, Nuutinen H, Turunen U, Färkkilä M.

Inflamm Bowel Dis. 2008 Oct;14(10):1392-8. doi: 10.1002/ibd.20490.

PMID:
18484671
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk